Cipla launches 'Covi-G' for COVID-19 rapid antibody detection-PR Newswire APAC

Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit

Cipla launches 'Covi-G' for COVID-19 rapid antibody detection-PR Newswire APAC

MUMBAI, India, Nov. 18, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid...

Read more: Cipla launches 'Covi-G' for COVID-19 rapid antibody detection-PR Newswire APAC

More Articles …

  1. APEC CEO Dialogues Malaysia 2020 Virtually Connects Asia-Pacific's Government and Business Leaders to Discuss Top Priorities in the Aftermath of the Pandemic
  2. NetSuite Helps Growing Businesses Adapt to Change and Build for the Future-PR Newswire APAC
  3. Kiri Align has partnered with Australian Fertiliser Services Association (AFSA), to provide a Digital Safety & Compliance Management Solution
  4. Apptio is the First Technology Business Management Vendor to Undergo "PROTECTED" Assessment Through the Information Security Registered Assessors Program (IRAP)
  5. Nintex Ranked a Leader in Workflow and Content Automation by Aragon Research-PR Newswire APAC
  6. ioneer Joins major US Industry Organisation Advocating for Zero Emission Transportation by 2030-PR Newswire APAC
  7. L'Oréal Paris is Delighted to Announce Hollywood Trailblazer Gemma Chan as International Spokesperson-PR Newswire APAC
  8. QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours-PR Newswire APAC
  9. Online Education Services (OES) Acquires Majority Stake in Construct-PR Newswire APAC
  10. Sydney puts on a show for Qantas Centenary-PR Newswire APAC